CSL

Melbourne, Australia Founded: 1916 • Age: 110 yrs
CSL is recognized as a global leader in biotechnology.

About CSL

CSL is a company based in Melbourne (Australia) founded in 1916. It operates as a Direct-to-Consumer (D2C), and Professional Services. CSL has completed 1 acquisition, including CSL Vifor. CSL offers products and services including CSL Behring Biotherapies, CSL Seqirus Vaccines, and CSL Vifor Therapies.

  • Headquarter Melbourne, Australia
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Csl Limited
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of CSL

CSL is a publicly listed company on the ASX with ticker symbol CSL in Australia, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: ASX · Ticker: CSL . Sector: Health technology · Australia

Products & Services of CSL

CSL offers a comprehensive portfolio of products and services, including CSL Behring Biotherapies, CSL Seqirus Vaccines, and CSL Vifor Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Biotherapies for rare and serious diseases are developed.

Influenza and other vaccines are produced globally.

Therapies for iron deficiency and nephrology are offered.

People of CSL
Headcount 5000-10000
Employee Profiles 417
Board Members and Advisors 8
Employee Profiles
People
Diego Sacristan
Head Of International; CSL Behring
People
Matt Tripp
Senior Financial Business Partner
People
Jordi Pont Arnaiz
Associate Director Sales & Marketing Commercial Spain
People
Saber Dini
Senior Data Scientist

Unlock access to complete

Board Members and Advisors
people
Carolyn Hewson
Director
people
Andrew Cuthbertson
Director
people
Alison Watkins
Director
people
Brian Daniels
Director

Unlock access to complete

Funding Insights of CSL

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by CSL

CSL has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include CSL Vifor. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Plasma-derived therapies and vaccines are provided for rare diseases.
1872
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - CSL

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Csl Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CSL

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about CSL

When was CSL founded?

CSL was founded in 1916.

Where is CSL located?

CSL is headquartered in Melbourne, Australia. It is registered at Melbourne, Victoria, Australia.

Who is the current CEO of CSL?

Paul McKenzie is the current CEO of CSL.

What does CSL do?

CSL is established as a prominent biotechnology company with operations through CSL Behring, CSL Seqirus, and CSL Vifor. The company is focused on developing and delivering biotherapies for rare and serious diseases, vaccines for public health, and therapies for iron deficiency and nephrology. Solutions are provided across multiple sectors including healthcare and pharmaceuticals, with an emphasis on innovation and patient care. A global presence is maintained with headquarters in Melbourne, Australia, and additional key locations worldwide.

What products or services does CSL offer?

CSL offers CSL Behring Biotherapies, CSL Seqirus Vaccines, and CSL Vifor Therapies.

Is CSL publicly traded?

Yes, CSL is publicly traded on ASX under the ticker symbol CSL.

How many acquisitions has CSL made?

CSL has made 1 acquisition, including CSL Vifor.

What is CSL's ticker symbol?

The ticker symbol of CSL is CSL on ASX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available